The modulation of Nrf2, as exemplified by fenofibrate, has proven effective in ameliorating diabetic retinopathy by reducing the ROS formation, retinal leukostasis, and vascular leakage [205]. This evidence concerns the gene NFE2L2 and diabetic retinopathy.